ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: Comparison with sporadic tumors from Ukrainian and French patients

Endocrine-Related Cancer

Volumn 12, Issue 1, 2005, Pages 173-183

  Di Cristofaro, J ^a   Vasko, V ^c,d   Savchenko, V ^c   Cherenko, S ^c   Larin, A ^c   Ringel, M D ^d   Saji, M ^d   Marcy, M ^b   Henry, J F ^a,b   Carayon, P ^a   De Micco, C ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Transplantation of Endocrine Organs and Tissues   (Ukraine)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CHERNOBYL ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; FALLOUT; FEMALE; GENE REARRANGEMENT; GENETIC EPIDEMIOLOGY; GEOGRAPHIC DISTRIBUTION; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE RET; PREVALENCE; PTC1 GENE; PTC3 GENE; RADIATION EXPOSURE; RADIOACTIVE CONTAMINATION; RNA EXTRACTION; THYROID ADENOMA; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

ACCIDENTS, RADIATION; ADULT; AGED; CARCINOMA, PAPILLARY; CHILD; FRANCE; GENE REARRANGEMENT; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; ONCOGENE PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; UKRAINE;

EID: 20144388955     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.00884     Document Type: Article

References (50)

1. Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, et al. 2002 Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. American Journal of Pathology 160 247-254.
2. Baverstock K, Egloff B, Pinchera A, Ruchti C & Williams D 1992 Thyroid cancer after Chernobyl. Nature 359 21-22.
3. Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G & Pierotti MA 1994 Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Research 54 2979-2985.
4. Bongarzone I, Fugazzola L, Vigneri P, Mariani L, Mondellini P, Pacini F, Basolo F, Pinchera A, Pilotti S & Pierotti MA 1996 Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 81 2006-2009.
5. Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M & Suarez HG 1997 High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogens 15 1263-1273.
6. Cherenko SM, Larin OS, Gorobeyko MB & Sichynava RM 2004 Clinical analysis of thyroid cancer in adult patients exposed to ionizing radiation due to the Chernobyl nuclear accident: 5-year comparative investigations based on the results of surgical treatment. World Journal of Surgery.
7. Cheung CC, Carydis B, Ezzat S, Bedard YC & Asa SL 2001 Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. Journal of Clinical Endocrinology and Metabolism 86 2187-2190.
8. Chua EL, Wu WM, Tran KT, McCarthy SW, Lauer CS, Dubourdieu D, Packham N, O'Brien CJ, Turtle JR & Dong Q 2000 Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia. Journal of Clinical Endocrinology and Metabolism 85 2733-2739.
9. Cinti R, Yin L, Ilc K, Berger N, Basolo F, Cuccato S, Giannini R, Torre G, Miccoli P, Amati P et al. 2000 RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH. Cytogenetics and Cell Genetics 88 56-61.
10. Delvincourt C, Patey M, Flament JB, Suarez HG, Larbre H, Jardillier JC & Delisle MJ 1996 Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region. Clinical Biochemistry 29 267-271.
11. Demidchik EP, Demidchik YE, Gedrevich ZE, et al. 2002 Thyroid cancer in Belarus. International Congress Series 1234 69-75.
12. de Vathaire F, Hardiman C, Shamsaldin A, Campbell S, Grimaud E, Hawkins M, Raquin M, Oberlin O, Diallo I, Zucker JM, et al. 1999 Thyroid carcinomas after irradiation for a first cancer during childhood. Archives of Internal Medicine 159 2713-2719.
13. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, et al. 2001 RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Journal of Clinical Endocrinology and Metabolism 86 3211-3216.
14. Fagin JA 2004 Challenging dogma in thyroid cancer molecular genetics-role of RET/PTC and BRAF in tumor initiation. Journal of Clinical Endocrinology and Metabolism 89 4264-4266.
15. Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL & Tuttle RM 2000 The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. Journal of Clinical Endocrinology and Metabolism 85 1170-1175.
16. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP, et al. 1995 Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Research 55 5617-5620.
17. Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M, et al. 2002 Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. American Journal of Pathology 160 2157-2167.
18. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A & Vecchio G 1990 PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60 557-563.
19. Hedinger C 1988 Histological Typing of Thyroid Tumours, 2nd edn. Berlin: Springer-Verlag.
20. Ishizaka Y, Kobayashi S, Ushijima T, Hirohashi S, Sugimura T & Nagao M 1991 Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 6 1667-1672.
21. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N & Akiyama M 1993 In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Research 53 2940-2943.
22. Ivanov VK, Tsyb AF, Gorsky AI, Maksyutov MA, Rastopchin EM, Konogorov AP, Korelo AM, Biryukov AP & Matyash VA 1997 Leukaemia and thyroid cancer in emergency workers of the Chernobyl accident: estimation of radiation risks (1986-1995). Radiation and Environmental Biophysics 36 9-16.
23. Ivanov VK, Tsyb AF, Petrov AV, Maksioutov MA, Shilyaeva TP & Kochergina EV 2002 Thyroid cancer incidence among liquidators of the Chernobyl accident. Absence of dependence of radiation risks on external radiation dose. Radiation and Environmental Biophysics 41 195-198.
24. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S & Ledent C 1996 Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137 375-378.
25. Kazakov VS, Demidchik EP & Astakhova LN 1992 Thyroid cancer after Chernobyl. Nature 359 21.
26. Klugbauer S, Lengfelder E, Demidchik EP & Rabes HM 1995 High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 11 2459-2467.
27. Lam KY, Lo CY & Leung PS 2002 High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas. European Journal of Endocrinology 147 741-745.
28. Lanzi C, Borrello MG, Bongarzone I, Migliazza A, Fusco A, Grieco M, Santoro M, Gambetta RA, Zunino F, Della Porta G, et al. 1992 Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene 7 2189-2194.
29. Lee CH, Hsu LS, Chi CW, Chen GD, Yang AH & Chen JY 1998 High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism 83 1629-1632.
30. Mizuno T, Iwamoto KS, Kyoizumi S, Nagamura H, Shinohara T, Koyama K, Seyama T & Hamatani K 2000 Preferential induction of RET/PTC1 rearrangement by X-ray irradiation. Oncogene 19 438-443.
31. Musholt TJ, Musholt PB, Khaladj N, Schulz D, Scheumann GF & Klempnauer J 2000 Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma. Surgery 128 984-993.
32. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H & Fagin JA 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Research 57 1690-1694.
33. Nikiforov YE 2002 RET/PTC rearrangement in thyroid tumors. Endocrine Pathology 13 3-16.
34. Pisarchik AV, Ermak G, Demidchik EP, Mikhalevich LS, Kartel NA & Figge J 1998a Low prevalence of the ret/ PTC3r1 rearrangement in a series of papillary thyroid carcinomas presenting in Belarus ten years post-Chernobyl. Thyroid 8 1003-1008.
35. Pisarchik AV, Ermak G, Fomicheva V, Kartel NA & Figge J 1998b The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus. Thyroid 8 133-139.
36. Pitkevitch VA, Ivanov VK, Tsyb AF, Maksyoutov MA, Matiash VA & Shchukina NV 1997 Exposure levels for persons involved in recovery operations after the Chernobyl accident. Statistical analysis based on the data of the Russian National Medical and Dosimetric Registry (RNMDR). Radiation and Environmental Biophysics 36 149-160.
37. Prisyazhiuk A, Pjatak OA, Buzanov VA, Reeves GK & Beral V 1991 Cancer in the Ukraine, post-Chernobyl. Lancet 338 1334-1335.
38. Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D & Klugbauer S 2000 Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post- chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clinical Cancer Research 6 1093-1103.
39. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA & Boice JD Jr 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiation Research 141 259-277.
40. Rosai J, Carcangiu ML & De Lellis 1992 Tumors of the thyroid gland. In: Atlas of tumor pathology, Fascicle S, series 3. Washington DC: Armed Force Institute of Pathology.
41. Sadetzki S, Calderon-Margalit R, Modan B, Srivastava S & Tuttle RM 2004 Ret/PTC activation in benign and malignant thyroid tumors arising in a population exposed to low-dose external-beam irradiation in childhood. Journal of Clinical Endocrinology and Metabolism 89 2281-2289.
42. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, et al. 1992 Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. Journal of Clinical Investigation 89 1517-1522.
43. Santoro M, Thomas GA, Vecchio G, Williams GH, Fusco A, Chiappetta G, Pozcharskaya V, Bogdanova TI, Demidchik EP, Cherstvoy ED, et al. 2000 Gene rearrangement and Chernobyl related thyroid cancers. British Journal of Cancer 82 315-322.
44. Schlumberger M, Metivier H & Pacini F 1999 [Chernobyl 13 years after: consequences for protection of populations]. Revue du Praticien 49 1489-1491.
45. Smida J, Salassidis K, Hieber L, Zitzelsberger H, Kellerer AM, Demidchik EP, Negele T, Spelsberg F, Lengfelder E, Werner M, et al. 1999 Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. International Journal of Cancer 80 32-38.
46. Stone R 2001 Nuclear radiation. Living in the shadow of Chornobyl. Science 292 420-426.
47. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, et al. 1999 High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. Journal of Clinical Endocrinology and Metabolism 84 4232-4238.
48. Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogdanova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P, et al. 2004 Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism 89 4272-4279.
49. Vasko V, Ferrand M, Di Cristofaro J, Carayon P, Henry JF & de Micco C 2003 Specific pattern of RAS oncogene mutations in follicular thyroid tumors. Journal of Clinical Endocrinology and Metabolism 88 2745-2752.
50. Vasko V, Saji M, Hardy E, Kruhlak M, Larin A, Savchenko V, Miyakawa M, Isozaki O, Murakami H, Tsushima T, et al. 2004 Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. Journal of Medical Genetics 41 161-170.